BREAKING NEWS : ETPN2020 goes fully virtual on Oct.14-15!

#ETPN2020 is the 15th annual event of the ETPN – European Technology Platform on Nanomedicine, to be held on Oct. 14-15, 2020, as a virtual event this year in the context of the COVID-19 pandemic. ETPN2020 is co-organized by the ETPN and IESL-FORTH. REGISTRATION & ABSTRACTION SUBMISSION ARE OPEN!

All information about the virtual conference ETPN2020 is available on our official website: www.etpn2020.eu

Know more

Ruth Schmid leads the totally renewed Executive Board of the ETPN!

Ruth Schmid , VP Marketing at SINTEF, has been elected new chairperson of the ETP Nanomedicine Executive Board during the General Assembly held on June 17th 2019 on the fist day of the Nanomed Europe 2019 event (NME19) in Braga, Portugal. She will lead the platform with the support of a brilliant and entirely renewed team, with notably Agnès Pottier (Head of Discovery at Nanobiotix) and Raymond Schiffelers (Professor in Nanomedicine at UMC Utrecht) as vice chairpersons. Meet the new ETPN ExBo!

Discover the new ETPN ExBo

SAVE THE DATE! Nanomed Europe 2021 #NME21 June 29th - July 1st, St. Gallen Switzerland

#NME21 is the merge of the 16th annual event of the ETPN & the European scientific conference ENM. After the great success of NME19 held in Braga, Portugal in 2019, NME21 is co-organized by the ETPN and Empa, the Swiss Federal Laboratories for Materials Science and Technology.

#NME21 will be the greatest opportunity in 2021 for you to meet the European Nanomedicine community, bringing together scientists, technology providers, entrepreneurs, industry, clinicians and policy makers. Scientific lectures on Nanomedicine & sessions about the clinical translation of nanomedical products will be held in parallel.

Know more

What is nanomedicine?

Nanomedicine is the application of nanotechnology to achieve innovation in healthcare. It uses the properties developed by a material at its nanometric scale 10-9 m which often differ in terms of physics, chemistry or biology from the same material at a bigger scale.

Moreover, the nanometric size is also the scale of many biological mechanisms in the human body allowing nanoparticles and nanomaterials to potentially cross natural barriers to access new sites of delivery and to interact with DNA or small proteins at different levels, in blood or within organs, tissues or cells.

Know more

ETPN strategic inputs

As a major pan-European industry-oriented initiative, the ETPN aims at strengthening Europe’s capabilities and competitiveness in the area of nanomedicine innovation. Since 2005 the ETPN published a number of strategic documents outlining the needs and roadmaps for nanomedicine research in Europe.

We have contributed to set up numerous European funded projects providing a first impression of the conditions for a suitable social and economic environment and the structural requirements for an efficient translation of R&D results into innovative nanomedicine.

Know more

ETPN support to innovation

Complementary to its strategic inputs as an ETP to shape and support public funding on the most promising areas of Nanomedicine, the ETPN has designed in 2014 unique technical infrastructures regrouped in a central instrument: the Nanomedicine Translation HUB.

These free of charge services support and accelerate the development of the best Nanomedicine projects from innovative design to clinical development.

Know more

Key reasons to become a member:

Meet new partners and end-users
Share your success stories
Benefit from unique advantages
Shape the future of Nanomedicine in europe
Promote and educate

Know more

Are you on the Nanomedicine map?

The NanoMed Map provides thorough insights into the nanomedicine community by showing all the actors of the ecosystem in Europe and beyond. It was initiated by NanoMed 2020, CSA project under FP7_Health.

See the map



Latest news

“Delivering the power of nanomedicine to patients today’. Read the latest position paper of the ETPN in the Journal of Controlled Release!

Jul 21, 2020

The ETPN is very proud and happy to share today our latest publication in the Journal of Controlled Release : “Delivering the power of nanomedicine to patients today”. This common position paper in open access is the best way to learn more about the real potential of...

SAVE THE DATE! #NME21 Nanomed Europe 2021 / June 29th – July 1st / St. Gallen – Switzerland

Jul 6, 2020

Dear colleagues, We are extremely pleased to announce the launch of Nanomed Europe 2021, NME21, which will take place from June 29th. to July 1st. 2021 in St. Gallen, Switzerland: www.nme21.eu #NME21 is the merge of the 16th annual event of the ETPN & the European...